sucroferric oxyhydroxide
Selected indexed studies
- Sucroferric Oxyhydroxide. (, 2006) [PMID:33226743]
- Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence. (J Nephrol, 2022) [PMID:35138627]
- Sucroferric oxyhydroxide for the treatment of hyperphosphatemia. (Expert Opin Pharmacother, 2018) [PMID:29985725]
_Worker-drafted node — pending editorial review._
Connections
sucroferric oxyhydroxide is a side effect of
Sources
- Efficacy and Safety of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in Chinese Dialysis Patients with Hyperphosphataemia: A Randomised, Open-Label, Multicentre, 12-Week Phase III Study. (2024) pubmed
- Sucroferric Oxyhydroxide. (2006) pubmed
- Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence. (2022) pubmed
- Sucroferric oxyhydroxide for the treatment of hyperphosphatemia. (2018) pubmed
- A safety evaluation of sucroferric oxyhydroxide for the treatment of hyperphosphatemia. (2021) pubmed
- Sucroferric oxyhydroxide: a review in hyperphosphataemia in chronic kidney disease patients undergoing dialysis. (2015) pubmed
- Efficacy and safety of sucroferric oxyhydroxide versus sevelamer carbonate: A systematic review and meta-analysis. (2025) pubmed
- Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide. (2014) pubmed
- A review of sucroferric oxyhydroxide for the treatment of hyperphosphatemia in patients receiving dialysis. (2014) pubmed
- Sucroferric oxyhydroxide (Velphoro) for hyperphosphatemia. (2014) pubmed